Compare FFWM & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFWM | LAB |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.1M | 449.9M |
| IPO Year | 2014 | 2011 |
| Metric | FFWM | LAB |
|---|---|---|
| Price | $5.41 | $1.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $6.17 | $1.35 |
| AVG Volume (30 Days) | 980.0K | ★ 2.2M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $159,621,000.00 | ★ $169,737,000.00 |
| Revenue This Year | $164.76 | N/A |
| Revenue Next Year | $10.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 47.55 | ★ 79.77 |
| 52 Week Low | $4.42 | $0.92 |
| 52 Week High | $8.14 | $2.25 |
| Indicator | FFWM | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 61.44 |
| Support Level | $5.04 | $1.28 |
| Resistance Level | $5.52 | $1.56 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 83.33 | 65.00 |
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.